| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vesicular Transport Proteins | 22 | 2021 | 87 | 6.420 |
Why?
|
| Cilia | 19 | 2020 | 94 | 5.270 |
Why?
|
| Kidney Tubules | 15 | 2019 | 80 | 3.660 |
Why?
|
| Kidney | 19 | 2021 | 945 | 3.180 |
Why?
|
| Zebrafish Proteins | 10 | 2020 | 100 | 2.760 |
Why?
|
| Exocytosis | 6 | 2019 | 34 | 1.890 |
Why?
|
| Epithelial Cells | 13 | 2016 | 431 | 1.710 |
Why?
|
| Dogs | 21 | 2019 | 490 | 1.680 |
Why?
|
| Zebrafish | 16 | 2021 | 187 | 1.650 |
Why?
|
| MAP Kinase Signaling System | 6 | 2014 | 247 | 1.590 |
Why?
|
| cdc42 GTP-Binding Protein | 6 | 2016 | 20 | 1.570 |
Why?
|
| Polycystic Kidney Diseases | 4 | 2014 | 39 | 1.390 |
Why?
|
| Animals | 63 | 2021 | 20881 | 1.370 |
Why?
|
| Membrane Proteins | 12 | 2021 | 617 | 1.360 |
Why?
|
| Cytoskeletal Proteins | 4 | 2016 | 108 | 1.280 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 4 | 2015 | 25 | 1.150 |
Why?
|
| Protein Transport | 7 | 2019 | 280 | 1.120 |
Why?
|
| Podocytes | 5 | 2021 | 113 | 1.090 |
Why?
|
| Mitogen-Activated Protein Kinases | 4 | 2014 | 250 | 1.020 |
Why?
|
| Hepatocyte Growth Factor | 9 | 2021 | 63 | 1.000 |
Why?
|
| Mice | 31 | 2021 | 8474 | 0.990 |
Why?
|
| Retina | 3 | 2017 | 252 | 0.970 |
Why?
|
| Wnt Proteins | 2 | 2014 | 57 | 0.970 |
Why?
|
| Disease Models, Animal | 10 | 2019 | 2550 | 0.910 |
Why?
|
| Mice, Knockout | 11 | 2021 | 1692 | 0.890 |
Why?
|
| Gene Knockdown Techniques | 8 | 2019 | 196 | 0.880 |
Why?
|
| Cell Line | 19 | 2021 | 1752 | 0.850 |
Why?
|
| Retinal Degeneration | 2 | 2021 | 75 | 0.830 |
Why?
|
| Morphogenesis | 6 | 2019 | 159 | 0.830 |
Why?
|
| Heart Valve Diseases | 3 | 2020 | 123 | 0.810 |
Why?
|
| Photoreceptor Cells | 2 | 2021 | 62 | 0.790 |
Why?
|
| Vision Disorders | 2 | 2021 | 94 | 0.760 |
Why?
|
| Phenotype | 4 | 2020 | 947 | 0.760 |
Why?
|
| Madin Darby Canine Kidney Cells | 6 | 2019 | 22 | 0.750 |
Why?
|
| Cell Polarity | 9 | 2014 | 49 | 0.750 |
Why?
|
| Aortic Valve | 2 | 2019 | 249 | 0.720 |
Why?
|
| Photoreceptor Cells, Vertebrate | 2 | 2018 | 46 | 0.720 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2014 | 320 | 0.700 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 4 | 2016 | 175 | 0.700 |
Why?
|
| Cysts | 2 | 2019 | 70 | 0.690 |
Why?
|
| Organogenesis | 3 | 2016 | 49 | 0.690 |
Why?
|
| Extracellular Vesicles | 1 | 2019 | 21 | 0.680 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2021 | 145 | 0.680 |
Why?
|
| Kidney Glomerulus | 2 | 2021 | 155 | 0.650 |
Why?
|
| Kidney Diseases, Cystic | 4 | 2015 | 31 | 0.650 |
Why?
|
| Nephrotic Syndrome | 1 | 2019 | 61 | 0.640 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2019 | 214 | 0.630 |
Why?
|
| Gene Deletion | 1 | 2019 | 235 | 0.620 |
Why?
|
| Endoplasmic Reticulum | 2 | 2012 | 148 | 0.600 |
Why?
|
| Aortic Valve Stenosis | 1 | 2019 | 177 | 0.590 |
Why?
|
| Membrane Transport Proteins | 2 | 2016 | 81 | 0.590 |
Why?
|
| Urothelium | 2 | 2015 | 22 | 0.570 |
Why?
|
| Mannose-Binding Lectins | 1 | 2016 | 8 | 0.570 |
Why?
|
| Renal Dialysis | 2 | 2010 | 174 | 0.560 |
Why?
|
| Golgi Apparatus | 1 | 2016 | 75 | 0.540 |
Why?
|
| Exosomes | 1 | 2016 | 44 | 0.540 |
Why?
|
| Reperfusion Injury | 4 | 2018 | 320 | 0.520 |
Why?
|
| Endocytosis | 2 | 2014 | 113 | 0.520 |
Why?
|
| Kidney Pelvis | 1 | 2015 | 12 | 0.510 |
Why?
|
| Ureteral Obstruction | 1 | 2015 | 25 | 0.510 |
Why?
|
| Carrier Proteins | 8 | 2020 | 597 | 0.500 |
Why?
|
| Signal Transduction | 10 | 2021 | 2689 | 0.490 |
Why?
|
| Phosphorylation | 8 | 2021 | 1200 | 0.490 |
Why?
|
| Heart Defects, Congenital | 1 | 2019 | 596 | 0.470 |
Why?
|
| Mice, Inbred C57BL | 9 | 2021 | 2791 | 0.470 |
Why?
|
| Kidney Diseases | 5 | 2019 | 307 | 0.470 |
Why?
|
| Eye Proteins | 1 | 2015 | 160 | 0.460 |
Why?
|
| Tissue Culture Techniques | 1 | 2014 | 62 | 0.460 |
Why?
|
| Forkhead Transcription Factors | 1 | 2014 | 94 | 0.450 |
Why?
|
| Humans | 41 | 2021 | 68618 | 0.440 |
Why?
|
| TRPP Cation Channels | 2 | 2011 | 20 | 0.430 |
Why?
|
| ErbB Receptors | 1 | 2014 | 239 | 0.430 |
Why?
|
| Enzyme Activation | 6 | 2014 | 791 | 0.430 |
Why?
|
| Oxidative Stress | 3 | 2014 | 718 | 0.430 |
Why?
|
| rho GTP-Binding Proteins | 2 | 2003 | 19 | 0.420 |
Why?
|
| Hospitals, Veterans | 2 | 2010 | 147 | 0.410 |
Why?
|
| Saccharomyces cerevisiae Proteins | 3 | 2003 | 123 | 0.410 |
Why?
|
| Nuclear Proteins | 1 | 2014 | 271 | 0.410 |
Why?
|
| Transcription Factors | 3 | 2020 | 753 | 0.400 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 181 | 0.400 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2015 | 328 | 0.400 |
Why?
|
| Acute Kidney Injury | 1 | 2014 | 232 | 0.390 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 498 | 0.390 |
Why?
|
| Protein Binding | 5 | 2021 | 1027 | 0.380 |
Why?
|
| Proteins | 3 | 2007 | 474 | 0.370 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2010 | 31 | 0.360 |
Why?
|
| Myosin Type I | 2 | 2021 | 20 | 0.350 |
Why?
|
| Kidney Tubules, Collecting | 2 | 2013 | 46 | 0.350 |
Why?
|
| Transfection | 7 | 2018 | 782 | 0.350 |
Why?
|
| Hospital Administration | 1 | 2009 | 43 | 0.330 |
Why?
|
| Bioethics | 1 | 2008 | 7 | 0.320 |
Why?
|
| Butadienes | 5 | 2013 | 26 | 0.310 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2009 | 130 | 0.310 |
Why?
|
| Vitamin A | 2 | 2020 | 111 | 0.310 |
Why?
|
| Nitriles | 5 | 2013 | 68 | 0.310 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2007 | 24 | 0.300 |
Why?
|
| Green Fluorescent Proteins | 4 | 2014 | 200 | 0.300 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2007 | 59 | 0.300 |
Why?
|
| Prostate | 3 | 1997 | 116 | 0.300 |
Why?
|
| Tight Junctions | 2 | 2004 | 25 | 0.290 |
Why?
|
| Thyroid Cartilage | 1 | 2007 | 2 | 0.290 |
Why?
|
| Intubation | 1 | 2007 | 20 | 0.290 |
Why?
|
| Cricoid Cartilage | 1 | 2007 | 10 | 0.290 |
Why?
|
| Animals, Newborn | 4 | 2015 | 396 | 0.290 |
Why?
|
| RNA, Messenger | 5 | 2019 | 1664 | 0.280 |
Why?
|
| Emergency Treatment | 1 | 2007 | 52 | 0.280 |
Why?
|
| Airway Obstruction | 1 | 2007 | 49 | 0.280 |
Why?
|
| Software | 1 | 2009 | 418 | 0.280 |
Why?
|
| Fibronectins | 1 | 2006 | 130 | 0.280 |
Why?
|
| DNA, Complementary | 2 | 2019 | 251 | 0.270 |
Why?
|
| Respiration, Artificial | 1 | 2007 | 190 | 0.270 |
Why?
|
| Tissue and Organ Procurement | 1 | 2008 | 164 | 0.270 |
Why?
|
| Wnt-5a Protein | 2 | 2014 | 5 | 0.250 |
Why?
|
| Mutation | 4 | 2017 | 1213 | 0.250 |
Why?
|
| Animals, Genetically Modified | 2 | 2014 | 63 | 0.240 |
Why?
|
| Acetobacteraceae | 1 | 2004 | 1 | 0.240 |
Why?
|
| Time Factors | 5 | 2019 | 4655 | 0.240 |
Why?
|
| Religion | 1 | 2004 | 23 | 0.240 |
Why?
|
| Peritonitis | 1 | 2004 | 46 | 0.240 |
Why?
|
| Fungal Proteins | 2 | 2002 | 37 | 0.240 |
Why?
|
| Peritoneal Dialysis | 1 | 2004 | 30 | 0.240 |
Why?
|
| Liver | 5 | 2021 | 1118 | 0.230 |
Why?
|
| Tumor Suppressor Proteins | 4 | 2019 | 194 | 0.230 |
Why?
|
| Ethics, Medical | 2 | 2008 | 86 | 0.230 |
Why?
|
| Fibrosis | 3 | 2019 | 371 | 0.230 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2004 | 62 | 0.230 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 3 | 2013 | 82 | 0.220 |
Why?
|
| HEK293 Cells | 2 | 2016 | 326 | 0.220 |
Why?
|
| Cell Differentiation | 7 | 2017 | 1034 | 0.210 |
Why?
|
| Hedgehog Proteins | 2 | 2020 | 38 | 0.210 |
Why?
|
| Epithelium | 5 | 2018 | 172 | 0.210 |
Why?
|
| Mitral Valve Prolapse | 2 | 2020 | 40 | 0.210 |
Why?
|
| ral GTP-Binding Proteins | 1 | 2002 | 3 | 0.210 |
Why?
|
| Cell Survival | 3 | 2020 | 901 | 0.210 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2002 | 15 | 0.210 |
Why?
|
| Receptors, Androgen | 3 | 1997 | 34 | 0.200 |
Why?
|
| Base Sequence | 3 | 2019 | 1015 | 0.200 |
Why?
|
| GTP Phosphohydrolases | 1 | 2002 | 46 | 0.200 |
Why?
|
| Ureter | 2 | 2005 | 16 | 0.200 |
Why?
|
| Glomerular Filtration Rate | 3 | 2021 | 274 | 0.200 |
Why?
|
| Doxorubicin | 2 | 2019 | 231 | 0.200 |
Why?
|
| Male | 20 | 2019 | 37321 | 0.190 |
Why?
|
| Mice, Transgenic | 2 | 2015 | 1033 | 0.190 |
Why?
|
| Attitude to Health | 1 | 2004 | 403 | 0.190 |
Why?
|
| Apoptosis | 3 | 2019 | 1641 | 0.190 |
Why?
|
| Genome-Wide Association Study | 2 | 2019 | 240 | 0.190 |
Why?
|
| RNA, Small Interfering | 3 | 2018 | 434 | 0.190 |
Why?
|
| Secretory Vesicles | 1 | 2000 | 6 | 0.190 |
Why?
|
| Cells, Cultured | 3 | 2019 | 2673 | 0.180 |
Why?
|
| Organ Size | 3 | 2016 | 242 | 0.180 |
Why?
|
| Blotting, Western | 3 | 2015 | 954 | 0.180 |
Why?
|
| Kidney Transplantation | 1 | 2008 | 839 | 0.180 |
Why?
|
| Cell Movement | 3 | 2019 | 630 | 0.180 |
Why?
|
| Proteinuria | 2 | 2019 | 136 | 0.180 |
Why?
|
| Puromycin Aminonucleoside | 1 | 2019 | 7 | 0.180 |
Why?
|
| Transforming Growth Factor beta | 2 | 2021 | 384 | 0.180 |
Why?
|
| Microscopy, Fluorescence | 2 | 2015 | 261 | 0.170 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2014 | 331 | 0.170 |
Why?
|
| Eye | 1 | 2020 | 89 | 0.170 |
Why?
|
| Gene Expression | 4 | 2016 | 770 | 0.170 |
Why?
|
| Rats | 6 | 2014 | 5300 | 0.170 |
Why?
|
| Judaism | 1 | 1999 | 1 | 0.170 |
Why?
|
| Cloning, Organism | 1 | 1999 | 1 | 0.170 |
Why?
|
| Gene Expression Regulation | 3 | 2019 | 1293 | 0.170 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 710 | 0.170 |
Why?
|
| Gene Frequency | 1 | 2019 | 207 | 0.170 |
Why?
|
| Urogenital System | 1 | 1999 | 6 | 0.170 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2019 | 18 | 0.160 |
Why?
|
| Chimera | 1 | 1999 | 33 | 0.160 |
Why?
|
| Retinoids | 1 | 2020 | 122 | 0.160 |
Why?
|
| SEC Translocation Channels | 2 | 2012 | 9 | 0.160 |
Why?
|
| Mitral Valve | 1 | 2020 | 166 | 0.160 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2019 | 204 | 0.160 |
Why?
|
| Homeostasis | 1 | 2020 | 291 | 0.160 |
Why?
|
| Reactive Oxygen Species | 3 | 2016 | 499 | 0.160 |
Why?
|
| Transcriptome | 1 | 2019 | 164 | 0.160 |
Why?
|
| Cell Lineage | 1 | 1999 | 146 | 0.150 |
Why?
|
| Diacylglycerol Kinase | 1 | 2018 | 8 | 0.150 |
Why?
|
| Genes | 1 | 1998 | 86 | 0.150 |
Why?
|
| Isodesmosine | 1 | 2017 | 6 | 0.150 |
Why?
|
| Spiral Ganglion | 1 | 2018 | 47 | 0.150 |
Why?
|
| Liver Cirrhosis | 1 | 2021 | 301 | 0.150 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2017 | 25 | 0.150 |
Why?
|
| Hair Cells, Auditory | 1 | 2018 | 60 | 0.150 |
Why?
|
| Gene Regulatory Networks | 2 | 2017 | 94 | 0.150 |
Why?
|
| Genotype | 1 | 2019 | 786 | 0.140 |
Why?
|
| Hearing | 1 | 2018 | 133 | 0.140 |
Why?
|
| Biological Transport, Active | 1 | 2016 | 49 | 0.140 |
Why?
|
| Polymerase Chain Reaction | 3 | 2007 | 492 | 0.140 |
Why?
|
| Trans-Activators | 1 | 1998 | 237 | 0.140 |
Why?
|
| In Vitro Techniques | 2 | 2013 | 765 | 0.140 |
Why?
|
| Phenylacetates | 1 | 1996 | 18 | 0.140 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 627 | 0.140 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2016 | 62 | 0.140 |
Why?
|
| Seminal Vesicles | 1 | 1996 | 7 | 0.130 |
Why?
|
| Fibroblasts | 1 | 2021 | 902 | 0.130 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2015 | 4 | 0.130 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 1996 | 77 | 0.130 |
Why?
|
| Anuria | 1 | 2015 | 3 | 0.130 |
Why?
|
| Nephrectomy | 1 | 2016 | 103 | 0.130 |
Why?
|
| Hydronephrosis | 1 | 2015 | 12 | 0.130 |
Why?
|
| Case-Control Studies | 1 | 2019 | 1553 | 0.130 |
Why?
|
| Nephrosis | 1 | 1995 | 6 | 0.120 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2016 | 167 | 0.120 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2014 | 48 | 0.120 |
Why?
|
| Mesoderm | 1 | 1996 | 231 | 0.120 |
Why?
|
| Gene Knockout Techniques | 1 | 2014 | 61 | 0.120 |
Why?
|
| Gene Silencing | 1 | 2015 | 137 | 0.120 |
Why?
|
| Kidney Failure, Chronic | 2 | 2010 | 365 | 0.120 |
Why?
|
| Extracellular Matrix | 4 | 2020 | 493 | 0.120 |
Why?
|
| Hyponatremia | 1 | 1994 | 20 | 0.120 |
Why?
|
| Water-Electrolyte Balance | 1 | 1994 | 43 | 0.120 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2015 | 87 | 0.120 |
Why?
|
| Genetic Testing | 1 | 2015 | 159 | 0.120 |
Why?
|
| Hydrogen Peroxide | 2 | 2016 | 168 | 0.110 |
Why?
|
| Precipitin Tests | 2 | 2004 | 88 | 0.110 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2014 | 74 | 0.110 |
Why?
|
| Models, Animal | 1 | 2014 | 252 | 0.110 |
Why?
|
| Kidney Tubules, Distal | 1 | 2013 | 15 | 0.110 |
Why?
|
| Adipose Tissue | 1 | 1995 | 221 | 0.110 |
Why?
|
| Female | 11 | 2019 | 38074 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-met | 2 | 2006 | 33 | 0.110 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 209 | 0.110 |
Why?
|
| Creatinine | 2 | 2013 | 243 | 0.110 |
Why?
|
| RNA Interference | 1 | 2014 | 266 | 0.110 |
Why?
|
| Cell Proliferation | 2 | 2017 | 1174 | 0.110 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2014 | 282 | 0.110 |
Why?
|
| Luminescent Proteins | 2 | 2003 | 57 | 0.100 |
Why?
|
| Neurons | 1 | 2018 | 881 | 0.100 |
Why?
|
| Enzyme Inhibitors | 3 | 2018 | 659 | 0.100 |
Why?
|
| Situs Inversus | 1 | 1992 | 13 | 0.100 |
Why?
|
| Models, Biological | 2 | 2011 | 981 | 0.100 |
Why?
|
| Rabbits | 1 | 2012 | 509 | 0.100 |
Why?
|
| Cholelithiasis | 1 | 1992 | 66 | 0.100 |
Why?
|
| rac1 GTP-Binding Protein | 2 | 2020 | 23 | 0.100 |
Why?
|
| Amino Acid Sequence | 1 | 2014 | 1083 | 0.100 |
Why?
|
| Ischemia | 1 | 2013 | 229 | 0.100 |
Why?
|
| Endoscopy, Digestive System | 1 | 1992 | 78 | 0.100 |
Why?
|
| Cell Membrane | 2 | 2003 | 525 | 0.100 |
Why?
|
| Carotid Artery Injuries | 1 | 1991 | 26 | 0.100 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 1447 | 0.100 |
Why?
|
| Neck Injuries | 1 | 1991 | 17 | 0.100 |
Why?
|
| Craniocerebral Trauma | 1 | 1991 | 50 | 0.090 |
Why?
|
| Single-Payer System | 1 | 2010 | 3 | 0.090 |
Why?
|
| Philadelphia | 1 | 2010 | 18 | 0.090 |
Why?
|
| Cerebral Infarction | 1 | 1991 | 103 | 0.090 |
Why?
|
| Intercellular Junctions | 2 | 2021 | 32 | 0.090 |
Why?
|
| Incidence | 1 | 2014 | 1603 | 0.090 |
Why?
|
| Catheters, Indwelling | 1 | 2010 | 72 | 0.090 |
Why?
|
| Immunohistochemistry | 3 | 2017 | 1174 | 0.090 |
Why?
|
| Oxidants | 1 | 2010 | 48 | 0.090 |
Why?
|
| Permeability | 1 | 2010 | 131 | 0.090 |
Why?
|
| Ownership | 1 | 2009 | 18 | 0.090 |
Why?
|
| Electric Impedance | 1 | 2010 | 131 | 0.080 |
Why?
|
| Immunoprecipitation | 1 | 2009 | 132 | 0.080 |
Why?
|
| Middle Aged | 5 | 2010 | 21147 | 0.080 |
Why?
|
| Fees and Charges | 1 | 2008 | 11 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 4 | 1997 | 2083 | 0.080 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 2077 | 0.080 |
Why?
|
| Cost-Benefit Analysis | 1 | 2010 | 504 | 0.080 |
Why?
|
| Morals | 1 | 2008 | 27 | 0.080 |
Why?
|
| Cadaver | 1 | 2008 | 136 | 0.080 |
Why?
|
| Waiting Lists | 1 | 2008 | 104 | 0.070 |
Why?
|
| DNA Primers | 1 | 2007 | 302 | 0.070 |
Why?
|
| Pulmonary Ventilation | 1 | 2007 | 28 | 0.070 |
Why?
|
| raf Kinases | 1 | 2006 | 6 | 0.070 |
Why?
|
| Tretinoin | 1 | 2007 | 92 | 0.070 |
Why?
|
| Testosterone | 2 | 1997 | 96 | 0.070 |
Why?
|
| Aged | 4 | 2010 | 14862 | 0.070 |
Why?
|
| Tissue Donors | 1 | 2008 | 195 | 0.070 |
Why?
|
| Flavonoids | 1 | 2006 | 109 | 0.070 |
Why?
|
| Living Donors | 1 | 2008 | 160 | 0.070 |
Why?
|
| Microscopy, Confocal | 2 | 2004 | 337 | 0.070 |
Why?
|
| Simvastatin | 1 | 2006 | 34 | 0.070 |
Why?
|
| Glomerulonephritis | 1 | 2006 | 77 | 0.060 |
Why?
|
| Claudins | 1 | 2004 | 6 | 0.060 |
Why?
|
| Tissue Fixation | 1 | 2005 | 58 | 0.060 |
Why?
|
| Ribotyping | 1 | 2004 | 1 | 0.060 |
Why?
|
| Metalloporphyrins | 2 | 2016 | 25 | 0.060 |
Why?
|
| Imipenem | 1 | 2004 | 9 | 0.060 |
Why?
|
| Viscera | 1 | 2004 | 16 | 0.060 |
Why?
|
| RNA, Bacterial | 1 | 2004 | 30 | 0.060 |
Why?
|
| Cohort Studies | 1 | 2010 | 2358 | 0.060 |
Why?
|
| Tobramycin | 1 | 2004 | 38 | 0.060 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2004 | 85 | 0.060 |
Why?
|
| Up-Regulation | 1 | 2006 | 682 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2004 | 150 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2004 | 147 | 0.060 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2006 | 212 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 322 | 0.060 |
Why?
|
| Receptors, Polymeric Immunoglobulin | 1 | 2003 | 1 | 0.060 |
Why?
|
| Indicators and Reagents | 1 | 2003 | 63 | 0.050 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2003 | 37 | 0.050 |
Why?
|
| Genes, Dominant | 1 | 2003 | 51 | 0.050 |
Why?
|
| Cell Culture Techniques | 1 | 2003 | 189 | 0.050 |
Why?
|
| Linear Models | 1 | 2004 | 521 | 0.050 |
Why?
|
| Matrix Metalloproteinases | 1 | 2004 | 223 | 0.050 |
Why?
|
| Drug Therapy, Combination | 1 | 2004 | 649 | 0.050 |
Why?
|
| Lung | 1 | 2007 | 849 | 0.050 |
Why?
|
| Yeasts | 1 | 2002 | 15 | 0.050 |
Why?
|
| Mammals | 1 | 2002 | 47 | 0.050 |
Why?
|
| Organelles | 1 | 2001 | 18 | 0.050 |
Why?
|
| Cell Compartmentation | 1 | 2001 | 41 | 0.050 |
Why?
|
| Patient Compliance | 1 | 2004 | 402 | 0.050 |
Why?
|
| Patient Satisfaction | 1 | 2004 | 378 | 0.050 |
Why?
|
| Biomarkers | 2 | 2015 | 1593 | 0.050 |
Why?
|
| Hepatic Stellate Cells | 1 | 2021 | 53 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2000 | 90 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2004 | 4848 | 0.040 |
Why?
|
| Adult | 3 | 2007 | 21403 | 0.040 |
Why?
|
| MAP Kinase Kinase 1 | 2 | 2013 | 22 | 0.040 |
Why?
|
| Muscle, Smooth | 1 | 2020 | 117 | 0.040 |
Why?
|
| Transcription, Genetic | 2 | 2019 | 562 | 0.040 |
Why?
|
| Organ Culture Techniques | 2 | 1996 | 122 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2000 | 376 | 0.040 |
Why?
|
| Neuropeptides | 1 | 2020 | 106 | 0.040 |
Why?
|
| Pedigree | 1 | 2019 | 159 | 0.040 |
Why?
|
| Mice, Inbred C3H | 1 | 1999 | 134 | 0.040 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2020 | 144 | 0.040 |
Why?
|
| Actins | 1 | 2020 | 249 | 0.040 |
Why?
|
| Mitosis | 1 | 1999 | 76 | 0.040 |
Why?
|
| gamma Catenin | 1 | 1998 | 11 | 0.040 |
Why?
|
| Desmoplakins | 1 | 1998 | 14 | 0.040 |
Why?
|
| Peptides | 1 | 2021 | 455 | 0.040 |
Why?
|
| Stereocilia | 1 | 2018 | 1 | 0.040 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2018 | 12 | 0.040 |
Why?
|
| Quinazolinones | 1 | 2018 | 7 | 0.040 |
Why?
|
| Neurites | 1 | 2018 | 18 | 0.040 |
Why?
|
| Organ of Corti | 1 | 2018 | 21 | 0.040 |
Why?
|
| Integrases | 1 | 2018 | 31 | 0.040 |
Why?
|
| Larva | 1 | 2018 | 39 | 0.040 |
Why?
|
| Intestinal Absorption | 1 | 2018 | 41 | 0.040 |
Why?
|
| Dependovirus | 1 | 2018 | 34 | 0.040 |
Why?
|
| Congenital Abnormalities | 1 | 1998 | 42 | 0.040 |
Why?
|
| beta Catenin | 1 | 1998 | 73 | 0.040 |
Why?
|
| 3T3 Cells | 1 | 2018 | 124 | 0.040 |
Why?
|
| Heart Valves | 1 | 2019 | 171 | 0.040 |
Why?
|
| Disease Progression | 2 | 2015 | 1038 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 1999 | 532 | 0.040 |
Why?
|
| Culture Media, Serum-Free | 1 | 1997 | 35 | 0.040 |
Why?
|
| Autoradiography | 1 | 1997 | 94 | 0.040 |
Why?
|
| Penis | 1 | 1997 | 25 | 0.040 |
Why?
|
| Protein Domains | 1 | 2017 | 74 | 0.040 |
Why?
|
| Biological Assay | 1 | 2018 | 88 | 0.040 |
Why?
|
| Piperidines | 1 | 2018 | 123 | 0.040 |
Why?
|
| Nerve Degeneration | 1 | 2018 | 134 | 0.040 |
Why?
|
| Molecular Docking Simulation | 1 | 2017 | 78 | 0.040 |
Why?
|
| Cell Adhesion Molecules | 1 | 1998 | 199 | 0.040 |
Why?
|
| United States | 1 | 2009 | 7367 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 1998 | 305 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2019 | 615 | 0.040 |
Why?
|
| Intestinal Mucosa | 1 | 2018 | 219 | 0.040 |
Why?
|
| Pancreas | 1 | 2018 | 225 | 0.030 |
Why?
|
| Growth Substances | 1 | 1996 | 77 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 1998 | 852 | 0.030 |
Why?
|
| Fibroblast Growth Factors | 1 | 1996 | 51 | 0.030 |
Why?
|
| Prostatic Hyperplasia | 1 | 1996 | 25 | 0.030 |
Why?
|
| Quality of Life | 1 | 2004 | 1515 | 0.030 |
Why?
|
| Eye Abnormalities | 1 | 2015 | 15 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2015 | 65 | 0.030 |
Why?
|
| Wound Healing | 1 | 2018 | 260 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 742 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 1851 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 97 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 103 | 0.030 |
Why?
|
| Ethylnitrosourea | 1 | 2015 | 9 | 0.030 |
Why?
|
| Microtubules | 1 | 2015 | 104 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2015 | 237 | 0.030 |
Why?
|
| Hearing Loss | 1 | 2018 | 154 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2015 | 114 | 0.030 |
Why?
|
| Abnormalities, Multiple | 1 | 2015 | 109 | 0.030 |
Why?
|
| Cerebellum | 1 | 2015 | 103 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 1995 | 63 | 0.030 |
Why?
|
| False Positive Reactions | 1 | 1995 | 95 | 0.030 |
Why?
|
| Cell Division | 1 | 1996 | 541 | 0.030 |
Why?
|
| Abdomen | 1 | 1995 | 80 | 0.030 |
Why?
|
| Amyloidosis | 1 | 1995 | 48 | 0.030 |
Why?
|
| Adolescent | 1 | 2007 | 8912 | 0.030 |
Why?
|
| Facial Injuries | 1 | 1994 | 10 | 0.030 |
Why?
|
| Blast Injuries | 1 | 1994 | 15 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2018 | 700 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2013 | 196 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 282 | 0.030 |
Why?
|
| Biopsy | 1 | 1995 | 540 | 0.030 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2013 | 126 | 0.030 |
Why?
|
| Gallstones | 1 | 1992 | 58 | 0.020 |
Why?
|
| Cholecystectomy | 1 | 1992 | 79 | 0.020 |
Why?
|
| Accidents, Home | 1 | 1991 | 9 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 786 | 0.020 |
Why?
|
| Sphincterotomy, Endoscopic | 1 | 1992 | 79 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2013 | 432 | 0.020 |
Why?
|
| Carotid Arteries | 1 | 1991 | 110 | 0.020 |
Why?
|
| Prognosis | 1 | 2015 | 2093 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2016 | 1451 | 0.020 |
Why?
|
| Laparoscopy | 1 | 1992 | 237 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2015 | 2007 | 0.020 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 1992 | 348 | 0.020 |
Why?
|
| Stents | 1 | 1992 | 657 | 0.020 |
Why?
|
| Mevalonic Acid | 1 | 2006 | 27 | 0.020 |
Why?
|
| Blood Urea Nitrogen | 1 | 2006 | 65 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2004 | 20 | 0.020 |
Why?
|
| Body Patterning | 1 | 2004 | 44 | 0.010 |
Why?
|
| Acute Disease | 1 | 2006 | 658 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1991 | 2223 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 1745 | 0.010 |
Why?
|
| LLC-PK1 Cells | 1 | 2001 | 4 | 0.010 |
Why?
|
| Uridine | 1 | 2001 | 8 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1991 | 2324 | 0.010 |
Why?
|
| Plasmids | 1 | 2001 | 258 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2001 | 191 | 0.010 |
Why?
|
| Swine | 1 | 2001 | 672 | 0.010 |
Why?
|
| Fibroblast Growth Factor 10 | 1 | 1996 | 3 | 0.010 |
Why?
|
| Fibroblast Growth Factor 7 | 1 | 1996 | 6 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1996 | 149 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1996 | 201 | 0.010 |
Why?
|
| DNA | 1 | 1996 | 597 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1996 | 511 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1996 | 689 | 0.010 |
Why?
|